TrialJournal for immunotherapy of cancer2022

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.

Rikke Boedker Holmstroem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.